Sex-specific eNOS activity and function in human endothelial cells

• Published in: Scientific reports 2017-08, Vol.7 (1), p.9612-13, Article 9612
• Main Authors: Cattaneo, Maria Grazia, Vanetti, Claudia, Decimo, Ilaria, Di Chio, Marzia, Martano, Giuseppe, Garrone, Giulia, Bifari, Francesco, Vicentini, Lucia Maria
• Format: Article
• Language: English
• Subjects: 101/58; 13/106; 13/31; 13/51; 13/89; 14; 14/19; 14/34; 38/90; 42/35; 631/80/304; 692/4019/592/16; 82; 82/80; 96; 96/1; Angiogenesis; Cardiovascular diseases; Cell proliferation; Endothelial cells; Enzymatic activity; Humanities and Social Sciences; mRNA; multidisciplinary; Nitric oxide; Nitric-oxide synthase; Science; Science (multidisciplinary); Sexual dimorphism
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-017-10139-x

Clinical and epidemiological data show that biological sex is one of the major determinants for the development and progression of cardiovascular disease (CVD). Impaired endothelial function, characterized by an imbalance in endothelial Nitric Oxide Synthase (eNOS) activity, precedes and accelerates the development of CVD. However, whether there is any sexual dimorphism in eNOS activity and function in endothelial cells (ECs) is still unknown. Here, by independently studying human male and female ECs, we found that female ECs expressed higher eNOS mRNA and protein levels both in vitro and ex vivo . The increased eNOS expression was associated to higher enzymatic activity and nitric oxide production. Pharmacological and genetic inhibition of eNOS affected migratory properties only in female ECs. In vitro angiogenesis experiments confirmed that sprouting mostly relied on eNOS-dependent migration in female ECs. At variance, capillary outgrowth from male ECs was independent of eNOS activity but required cell proliferation. In this study, we found sex-specific differences in the EC expression, activity, and function of eNOS. This intrinsic sexual dimorphism of ECs should be further evaluated to achieve more effective and precise strategies for the prevention and therapy of diseases associated to an impaired endothelial function such as CVD and pathological angiogenesis.